DotBio
Chemicals & Related Products · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Research Link 05-35/36/37, Singapore, ...Phone Number
+65 69060743Website
www.dotbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About DotBio
DotBio is a biopharmaceutical company that specializes in next-generation domain antibody therapies. Utilizing its proprietary DotBody technology platform, the company creates multi-functional and intracellular antibody therapies derived from stabilized human VH domains. DotBio's innovative approach allows for the rapid generation of bi- and tri-specific antibodies, antibody-drug conjugates, and intracellular antibodies. The company aims to serve clients in the biopharmaceutical sector looking for advanced therapeutic solutions.Explore more
DotBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DotBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
DotBio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when DotBio launches new products
Check if DotBio has recently received funding, and reach out quickly before it becomes old news!
Click to see if DotBio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at DotBio
Earning: See what the market has to say on DotBio recently announced quarterly report
Funding: Get notified immidiatlly once DotBio has new funding data
Check out if DotBio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
DotBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
DotBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DotBio.
DotBio financials insights
Gather financial insights about DotBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$5.6M
DotBio Tech Stack
A closer look at the technologies used by DotBio
DotBio News & Media
Junshi Biosciences and DotBio Announce Collaboration to Develop Next-Generation Antibody Therapy with DotBody Module
SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biociences Co., Ltd (“Junshi Biosciences”, HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and DotBio Pte. Ltd (“DotBio”), a biotech company specialized in next generation antibody therapies, announced today that they have entered into a collaboration to develop next-generation antibody therapies. JunshCStone Pharmaceuticals and DotBio sign a global discovery collaboration and option agreement to expand emerging portfolio of next-generation innovative therapeutics
The two sides will jointly develop up to three preclinical first-in-class or best-in-class next-generation antibody therapies, for which CStone would lead the design of the target combination based on the intended mechanism of action and DotBio will lead the design and engineering of the molecules CStone will take an equity position in DotBio, a biotech company specialized in next generation antibody therapies This partnership marks the gear up of CStone's Pipeline 2.0 strategy bolstering its
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DotBio
Sign Up For FreeTo access detailed company insights
DotBio is a biopharmaceutical company that specializes in next-generation domain antibody therapies. Utilizing its proprietary DotBody technology platform, the company creates multi-functional and intracellular antibody therapies derived from stabilized human VH domains. DotBio's innovative approach allows for the rapid generation of bi- and tri-sp... Read More
